心血管磁共振评估恢复性肌钙蛋白阳性 COVID-19 患者的心肌损伤模式。
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance.
机构信息
Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK.
Institute of Cardiovascular Science, University College London, UK.
出版信息
Eur Heart J. 2021 May 14;42(19):1866-1878. doi: 10.1093/eurheartj/ehab075.
BACKGROUND
Troponin elevation is common in hospitalized COVID-19 patients, but underlying aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic resonance (CMR) to assess myocardial injury in recovered COVID-19 patients.
METHODS AND RESULTS
One hundred and forty-eight patients (64 ± 12 years, 70% male) with severe COVID-19 infection [all requiring hospital admission, 48 (32%) requiring ventilatory support] and troponin elevation discharged from six hospitals underwent convalescent CMR (including adenosine stress perfusion if indicated) at median 68 days. Left ventricular (LV) function was normal in 89% (ejection fraction 67% ± 11%). Late gadolinium enhancement and/or ischaemia was found in 54% (80/148). This comprised myocarditis-like scar in 26% (39/148), infarction and/or ischaemia in 22% (32/148) and dual pathology in 6% (9/148). Myocarditis-like injury was limited to three or less myocardial segments in 88% (35/40) of cases with no associated LV dysfunction; of these, 30% had active myocarditis. Myocardial infarction was found in 19% (28/148) and inducible ischaemia in 26% (20/76) of those undergoing stress perfusion (including 7 with both infarction and ischaemia). Of patients with ischaemic injury pattern, 66% (27/41) had no past history of coronary disease. There was no evidence of diffuse fibrosis or oedema in the remote myocardium (T1: COVID-19 patients 1033 ± 41 ms vs. matched controls 1028 ± 35 ms; T2: COVID-19 46 ± 3 ms vs. matched controls 47 ± 3 ms).
CONCLUSIONS
During convalescence after severe COVID-19 infection with troponin elevation, myocarditis-like injury can be encountered, with limited extent and minimal functional consequence. In a proportion of patients, there is evidence of possible ongoing localized inflammation. A quarter of patients had ischaemic heart disease, of which two-thirds had no previous history. Whether these observed findings represent pre-existing clinically silent disease or de novo COVID-19-related changes remain undetermined. Diffuse oedema or fibrosis was not detected.
背景
肌钙蛋白升高在住院的 COVID-19 患者中很常见,但潜在的病因尚不清楚。我们使用多参数心血管磁共振(CMR)评估康复的 COVID-19 患者的心肌损伤。
方法和结果
148 名患有严重 COVID-19 感染的患者(64±12 岁,70%为男性)[均需要住院治疗,48%(32%)需要通气支持]在六家医院接受了恢复期 CMR(如果有指征则包括腺苷应激灌注),中位数为 68 天。89%(射血分数 67%±11%)的左心室(LV)功能正常。54%(80/148)发现晚期钆增强和/或缺血。这包括心肌炎样瘢痕 26%(39/148)、梗死和/或缺血 22%(32/148)和双重病理学 6%(9/148)。心肌炎样损伤在 88%(35/40)的病例中局限于三个或更少的心肌节段,且无相关 LV 功能障碍;其中 30%有活动性心肌炎。在接受应激灌注的患者中发现心肌梗死 19%(28/148)和可诱导缺血 26%(20/76)(包括 7 例既有梗死又有缺血)。有缺血性损伤模式的患者中,66%(27/41)无既往冠心病史。在远程心肌中没有弥漫性纤维化或水肿的证据(T1:COVID-19 患者 1033±41 ms 与匹配对照 1028±35 ms;T2:COVID-19 46±3 ms 与匹配对照 47±3 ms)。
结论
在 COVID-19 严重感染后伴有肌钙蛋白升高的恢复期,可能会出现心肌炎样损伤,其范围有限,功能后果极小。在一部分患者中,有证据表明可能存在持续的局部炎症。四分之一的患者有缺血性心脏病,其中三分之二无既往病史。这些观察到的发现是代表先前存在的临床无症状疾病还是新出现的 COVID-19 相关变化仍未确定。未发现弥漫性水肿或纤维化。